EUVIMEDEUVIMED entdecken
Crossref

Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers

Bruno Pereira Dos Santos, Juliana Nichterwitz Scherer, Patrícia Pacheco Viola, Bruna Govoni, Mailton Vasconcelos, Carolina Silveira Dalanhol, Gabriela Ramos Borges, Giovanna Cristiano de Gouveia, Ana Carolina Furiozo Arantes, Aline Franco Martins, José Luiz da Costa, Marilyn A Huestis iD und 1 weitere

Journal of Analytical Toxicology · 2025

DOI: 10.1093/jat/bkaf033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2025. Verfasst von Bruno Pereira Dos Santos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre (HCPA), Av. Protásio Alves, 211, Santa Cecília, Porto Alegre, RS 90035-903…. Hauptthemen laut MEDLINE: Substance Abuse Detection, Saliva, Cocaine, Methamphetamine. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Secretaria Nacional de Políticas sobre Drogas e Gestão de Ativos (SENAD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimulant use while driving is a high-risk factor for collisions and fatalities. In recent years, several strategies to curtail impaired driving were employed on highways, including on-site oral fluid testing. This study evaluated four roadside oral fluid testing devices (AquilaScan®, Dräger DrugTest®, Druglizer®, and DrugWipe®) for the detection of amphetamine, methamphetamine, and cocaine in oral fluid from Brazilian drivers. Overall, 8985 screening tests were conducted, and LC–MS-MS analysis was performed on 46% of the oral fluid samples. Screening and confirmatory test results were compared considering the manufacturers’ and Substance Abuse and Mental Health Services Administration’s recommended cutoff concentrations. Performance reliability data are available for well-known oral fluid screening devices such as the Dräger DrugTest® or Securetec DrugWipe®, but most evaluations were based on highly prevalent cannabinoid results. In many cases, there were insufficient data to evaluate performance of other drug classes, including reliability data for amphetamines and cocaine that are presented here. Approximately, 3.0% of samples screened positive for amphetamine, 0.9% for methamphetamine, and 2.6% for cocaine. Efficiency was higher than 93.9% for all devices, but other parameters varied considerably, with sensitivity 56.4–100% and positive predictive value 4.2–87.1%. When considering the recommended minimum of 80% performance criteria suggested by the Driving Under the Influence of Drugs, Alcohol, and Medicines study, the Dräger DrugTest® was the only device to achieve satisfactory sensitivity, specificity, and efficiency for these stimulants at multiple evaluated cutoffs. Given the observed variability between devices, a detailed evaluation of the analytical performance of roadside oral fluid testing devices is advised before implementation in traffic enforcement actions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse DetectionSalivaCocaineMethamphetamineAmphetamineDriving Under the InfluenceAutomobile DrivingHumansBrazilReproducibility of ResultsTandem Mass SpectrometryChromatography, Liquid

Substanzen

CocaineMethamphetamineAmphetamine

Autor:innen und Institutionen

  • Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre (HCPA), Av. Protásio Alves, 211, Santa Cecília, Porto Alegre, RS 90035-903, Brazil.
  • Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS 90050-170, Brazil.
  • Programa de Pós-Graduação em Saúde Coletiva, Universidade do Vale do Rio dos Sinos (UNISINOS), São Leopoldo, RS 93022-750, Brazil.
  • Campinas Poison Control Center, University of Campinas (UNICAMP), Campinas, SP 13083-859, Brazil.
  • Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, SP 13083-859, Brazil.
  • Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA 19107, USA.

ORCID-Profile: Marilyn A Huestis

Förderung

  • Secretaria Nacional de Políticas sobre Drogas e Gestão de Ativos (SENAD)

Zitieren

APA

Dos Santos, B. P., Scherer, J. N., Viola, P. P., Govoni, B., Vasconcelos, M., Dalanhol, C. S., Borges, G. R., de Gouveia, G. C., Arantes, A. C. F., Martins, A. F., da Costa, J. L., Huestis, M. A., & Pechansky, F. (2025). Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaf033

Vancouver

Dos Santos BP, Scherer JN, Viola PP, Govoni B, Vasconcelos M, Dalanhol CS, et al. Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers. Journal of Analytical Toxicology. 2025. doi:10.1093/jat/bkaf033

BibTeX
@article{DosSantos2025,
  author = {Dos Santos, Bruno Pereira and Scherer, Juliana Nichterwitz and Viola, Patrícia Pacheco and Govoni, Bruna and Vasconcelos, Mailton and Dalanhol, Carolina Silveira and Borges, Gabriela Ramos and de Gouveia, Giovanna Cristiano and Arantes, Ana Carolina Furiozo and Martins, Aline Franco and da Costa, José Luiz and Huestis, Marilyn A and Pechansky, Flavio},
  title = {Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers},
  journal = {Journal of Analytical Toxicology},
  year = {2025},
  doi = {10.1093/jat/bkaf033}
}
Kostenlos starten →